TrialHead & neck2014

Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329.

Binu Malhotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.